Sandro Pasquali

12PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingDisease surveillanceSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|Apr 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

|May 27, 2025
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).

Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong

|Sep 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

Silvia Stacchiotti, Silvia Martini, Sandro Pasquali

|Aug 12, 2024
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Anna Maria Frezza, Hugh Leonard, Ninna Aggerholm-Pedersen

|Jan 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo

Pageof 2

Frequent Collaborators

6 joint publications

Alessandro Gronchi

4 joint publications

Jean-Yves Blay

4 joint publications

Silvia Stacchiotti

4 joint publications

Anna Maria Frezza